Pharmaceutical / Drug Definition :
Inhibits and desensitizes GnRH receptors, thus inhibiting gonadotropin secretion when given continuously. This inhibition causes initial increase and then profound decrease in luteinizing hormone and follicle-stimulating hormone levels and, ultimately, reduces testosterone and estrogen sex hormones.
In the United States, Leuprolide Acetate is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Leuprolide Acetate.
FDA Label Requirements and Exceptions
FDA Import Information
Leuprolide Acetate (Leuprolide Acetate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Leuprolide Acetate (Leuprolide Acetate Suppliers)
- Processors Leuprolide Acetate
- Repackers Leuprolide Acetate
- Relabelers Leuprolide Acetate
- Exporters Leuprolide Acetate
- Importers Leuprolide Acetate
For more information about Leuprolide Acetate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.